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Abstract
Recent meta-analyses have found no association between heart disease and
dietary saturated fat; however, higher proportions of plasma saturated fatty acids
(SFA) predict greater risk for developing type-2 diabetes and heart disease. These
observations suggest a disconnect between dietary saturated fat and plasma SFA,
but few controlled feeding studies have specifically examined how varying
saturated fat intake across a broad range affects circulating SFA levels. Sixteen
adults with metabolic syndrome (age 44.9¡9.9 yr, BMI 37.9¡6.3 kg/m2) were fed
six 3-wk diets that progressively increased carbohydrate (from 47 to 346 g/day)
with concomitant decreases in total and saturated fat. Despite a distinct increase in
saturated fat intake from baseline to the low-carbohydrate diet (46 to 84 g/day), and
then a gradual decrease in saturated fat to 32 g/day at the highest carbohydrate
phase, there were no significant changes in the proportion of total SFA in any
plasma lipid fractions. Whereas plasma saturated fat remained relatively stable, the
proportion of palmitoleic acid in plasma triglyceride and cholesteryl ester was
significantly and uniformly reduced as carbohydrate intake decreased, and then
gradually increased as dietary carbohydrate was re-introduced. The results show that
dietary and plasma saturated fat are not related, and that increasing dietary
carbohydrate across a range of intakes promotes incremental increases in plasma
palmitoleic acid, a biomarker consistently associated with adverse health outcomes.
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Introduction
Current dietary guidelines recommend that Americans decrease saturated fat to 7–
10% of total energy and to consume the majority of calories from carbohydrate
[1]. To accomplish these goals requires limiting whole foods that contain
saturated fat (e.g., beef, eggs, high-fat dairy). A reduction in dietary saturated fat
typically results in greater carbohydrate intake. The metabolic and clinical effects
of replacing dietary saturated fat with carbohydrate are complicated and vary
from person-to-person, but on a population level such a dietary manipulation
may have untoward outcomes [2].
A consequence of consuming dietary sugars and starches above levels that can
be directly oxidized is that a greater proportion is converted to fat (i.e., de novo
lipogenesis). De novo lipogenesis (DNL) increases several-fold when carbohydrate
is fed above energy needs [3], but isocaloric high-carbohydrate diets [4] and high-
carbohydrate meals [5, 6] also promote DNL and hypertriglyceridemia in
individuals with insulin resistance. The major product of DNL is palmitate (16:0),
a saturated fatty acid (SFA), but monounsaturated fatty acids (MUFA) are also
formed as a result of desaturation, most notably palmitoleic acid (cis-16:1n-7).
Healthy men overfed carbohydrate showed increased very low-density lipopro-
tein-triglyceride (VLDL-TG) palmitic (28.3 to 37.9%) and palmitoleic (3.8 to
10.0%) acids [3]. Thus, high-carbohydrate intake in individuals with an impaired
ability to oxidize glucose stimulates DNL and secretion of SFA- and MUFA-
enriched VLDL particles; a serum profile associated with insulin resistance [7].
In observational studies, the most consistent nonessential fatty acid that
predicts metabolic syndrome [8, 9] and type-2 diabetes [10–14] is palmitoleic acid
measured in erythrocytes, plasma cholesteryl ester (CE), or plasma phospholipid
(PL). Palmitic and total SFA are usually significant predictors as well. In non-
diabetic men that were followed for 5 yr, higher proportions of erythrocyte
palmitoleic acid were significantly associated with worsening of hyperglycemia
[15]. Higher proportions of palmitic acid and total SFA in blood lipids are
associated with increased risk for heart disease [16–20] and more recently cancer
[21]. Thus, a large body of evidence indicates that higher proportions of blood
SFA and palmitoleic acid are associated with the pathophysiology of glucose
intolerance and cardiovascular disease.
It is commonly believed that circulating fatty acids reflect dietary intake, but the
associations are weak, especially for SFA and MUFA. In controlled isocaloric or
hypocaloric experiments, when dietary carbohydrate is reduced, circulating levels
of lipogenic fatty acids (i.e., palmitoleic, palmitic and total SFA) consistently
decrease, despite higher saturated fat intake [22–25]. Proportionately, palmitoleic
acid is the most responsive fatty acid to carbohydrate overfeeding [3] and it drops
precipitously when carbohydrate is limited to less than 50 g/day [24, 25]. The
results of these studies provide credible evidence that plasma SFA correlates
poorly with dietary saturated fat and better with carbohydrate, and that plasma
palmitoleic acid in particular is metabolically aligned with processing of dietary
carbohydrate.
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Although accumulation of SFA in circulating lipid fractions appears to be
modulated by carbohydrate more than dietary saturated fat, there are no
controlled studies examining this premise across multiple levels of carbohydrate
in the same person. The aim of this study was to determine how incremental
increases in carbohydrate, and decreases in fat, affect plasma SFA and palmitoleic
acid in adults with metabolic syndrome who were carefully fed moderately
hypocaloric diets for 21 wk. A primary hypothesis was that, despite consuming
substantially higher amounts of saturated fat, plasma SFA would remain
unchanged in the context of lower carbohydrate intake. Plasma palmitoleic acid
was hypothesized to decrease sharply after a very low carbohydrate diet and
gradually increase as a function of incremental increases in carbohydrate intake.
Methods
Experimental Approach
The experimental design involved a single arm, mildly hypocaloric, ,18-wk
feeding intervention (following a 3-week run-in diet) that incrementally adjusted
carbohydrate and fat levels over six 3-wk phases (Fig 1). Participants (n516) were
fed a low carbohydrate diet first and gradually transitioned to a high carbohydrate
diet over six sequential phases (C1RC2RC3RC4RC5RC6) during which time
saturated fat was decreased. Blood was collected at baseline, after the run-in diet,
and after each phase (before transition to the next diet) to determine fatty acid
composition and other blood-borne markers.
Study Participants
Sixteen overweight/obese men and women 30-66 years old, with a BMI between
27–50 kg/m2 participated in this controlled dietary intervention (Table 1).
Participants had metabolic syndrome defined as having three or more of the
following criteria: waist circumference (>101.6 cm men, >88.9 cm women),
blood pressure (>130/85 mm Hg) or current use of antihypertensive medication,
and fasting plasma glucose (>100 mg/dL), triglycerides (>150 mg/dL), and
HDL-C (,40 mg/dL men, ,50 mg/dL women). Subjects were medically screened
and excluded if they had a diagnosis of Type I or II Diabetes, liver, kidney, or
other metabolic or endocrine dysfunction. Subjects were excluded if they were
trying to lose weight or had a body mass change of ¡3 kg in the previous 3 mo.
Physically active participants were asked to maintain their same levels of activity
(verified by activity records) and sedentary individuals did not begin an exercise
program in order to limit possible confounding effects on the dependent
variables. Subjects were informed of the purpose and possible risks of the
investigation prior to signing an informed consent document approved by the
University of Connecticut Institutional Review Board who approved this study.
Carbohydrate Effects on Saturated Fatty Acids and Palmitoleic Acid
PLOS ONE | DOI:10.1371/journal.pone.0113605 November 21, 2014 3 / 16
Dietary Intervention
Six diets were developed that spanned a range of carbohydrate from
approximately 50 to 350 g/day (C1RC2RC3RC4RC5RC6) using nutrient
analysis software (Nutritionist Pro, Axxya Systems, Stafford, TX). The highest
carbohydrate phase (C6) was designed to model national dietary recommenda-
tions. While carbohydrate was adjusted every 3 wk, total fat decreased
proportionately so that total energy remained constant. Saturated fat was 40% of
total fat for all phases. Protein was constant at 1.8 g/kg reference body weight
determined from midpoint of Metropolitan Height-Weight Tables. Based on
individual resting metabolic needs and activity factors (1.2–1.5) obtained at
baseline, the diets were designed to provide a 300 kcal/day energy deficit to induce
moderate weight loss and motivation for subjects to continue participation in the
21 wk experiment. Thus, total caloric and protein intake for each individual did
not change throughout the study. Estimated nutrient composition of select diets
showed high concordance with chemical analysis (Exova, Portland, OR).
For each diet phase 7-day rotational menus were developed that included a
wide range of whole foods. Beef, eggs, and dairy were used daily throughout all
diet phases as primary sources of saturated fat. For the low carbohydrate diet
phases, higher-fat beef and meats, whole eggs, and full-fat dairy products (e.g.,
cheese, whole milk yogurt, cream, butter) were emphasized. For the higher
carbohydrate diet phases with lower saturated fat, leaner versions of beef, egg
substitutes, and low-fat dairy (e.g., reduced-fat dairy, skim milk, low-fat/non-fat
yogurt) were used instead. Whole grain and relatively low glycemic index
carbohydrate sources were emphasized.
Prior to the 18-wk controlled feeding intervention, subjects were counseled to
consume a 3-wk very low-carbohydrate run-in diet that mirrored the first low-
carbohydrate feeding phase (C1, ,50 g carbohydrate/day) in order to initiate
metabolic adaptations to carbohydrate restriction. Three-day diet records were
utilized to determine nutrient intake prior to baseline and during the run-in diet.
Following the run-in period, subjects were provided with all food for 18 wk,
which was prepared and packaged by staff in our research kitchen. Food was
packaged and labeled per individual serving sizes based on individual caloric and
Figure 1. Experimental approach. CHO5carbohydrate, SFA 5 saturated fat.
doi:10.1371/journal.pone.0113605.g001
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Table 1. Baseline subject characteristics1.
Sex (M/F) 12/4
Age (yr) 44.9¡9.9
Body mass (kg) 108.4¡15.1
BMI (kg/m2) 37.9¡6.3
Waist Circumference (cm) 116.8¡10.5
Body Fat (%)2 40.0¡3.2
Total cholesterol (mg/dL) 191¡34
LDL-C (mg/dL) 123¡27
HDL-C (mg/dL) 42¡8
Triglycerides (mg/dL) 134¡54
Glucose (mg/dL) 100¡5
Insulin (pmol/L) 93¡70
Insulin Resistance (HOMA)3 3.3¡2.0
Ketones (mmol/L) 0.11¡0.06
Systolic Blood Pressure (mmHg)* 122¡10
Diastolic Blood Pressure (mmHg)* 83¡11
Plasma Triglyceride (wt%)
14:0 1.47¡0.44
16:0 25.22¡2.68
18:0 3.69¡0.94
16:1 3.87¡0.90
18:1 35.98¡2.24
Total SFA 31.05¡3.56
Total MUFA 40.81¡2.44
Plasma Cholesteryl Ester (wt%)
14:0 1.07¡0.90
16:0 11.03¡1.44
18:0 1.04¡0.61
16:1 3.10¡1.17
18:1 16.00¡1.65
Total SFA 13.69¡2.92
Total MUFA 19.55¡2.42
Plasma Phospholipid (wt%)
14:0 0.36¡0.14
16:0 26.32¡1.95
18:0 14.76¡1.57
16:1 0.77¡0.22
18:1 8.76¡0.92
Total SFA 43.51¡1.90
Total MUFA 11.50¡0.98
1Values are mean ¡ SD (range).
2Determined by dual-energy X-ray absorptiometry.
3HOMA 5 homeostatic model assessment 5 [fasting glucose (mmol/L) x insulin (mU/L)]/22.5.
*5 subjects were using anti-hypertensive medications.
doi:10.1371/journal.pone.0113605.t001
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macronutrient needs and was picked up by the subjects 3-4 times/wk. If unable to
travel to obtain the food, arrangements were made to ensure the subject received
his/her food as planned. No other foods or beverages were allowed except very-
low/non-caloric products (e.g., coffee, tea, water, diet soda). All food containers
were returned unwashed and inspected to document that all food was consumed.
Measurements
Subjects arrived to the laboratory following a minimum 12-hr fast and 24-hr
abstinence from exercise, caffeine, over the counter medications, and alcohol.
Body mass was measured using a digital scale (Ohaus Corp., Parsippany, NJ),
height was measured with a stadiometer, and waist circumference was assessed
using a standard tape measure performed by the same person. Resting energy
expenditure and substrate oxidation was measured by indirect calorimetry
(Parvomedics TrueOne 2400 metabolic cart) in a thermal neutral room. The
metabolic carts were calibrated with a standard gas mixture each morning.
Subjects relaxed quietly for approximately 30 min and oxygen consumption
(VO2) and carbohydrate expiration (VCO2) were averaged for 15 min to
determine respiratory exchange ratio (VCO2/VO2). Prior to blood collection,
subjects provided a small urine sample to assess specific gravity as a measure of
hydration. Subjects with a USG>1.025 were asked to consume water and wait
30 min before another urine sample was measured.
Blood samples were obtained from an arm vein after subjects rested quietly for
15 min in the supine position. Whole blood was collected into tubes with a serum
separator and ethylenediaminetetraacetic acid (EDTA). Tubes with serum
separator remained at room temperature for 15 min prior to centrifugation to
allow clotting to occur. Whole blood was centrifuged at 15006g for 15 min and
4 C˚, aliquoted into storage tubes, and stored in ultra-low freezers for batch
analysis. A portion of serum (,7 mL) was immediately sent on ice to a certified
medical laboratory (Quest Diagnostics, Wallingford, CT) for determination of
glucose, total cholesterol (TC), HDL-C, TG, and calculated LDL-C concentrations
using automated enzymatic procedures (Olympus America Inc., Melville, NY).
Subjects returned to the laboratory for a second fasting blood draw 24–48 hr after
visit 1 to repeat glucose and lipid testing. The results from both days were
averaged to account for day-to-day variability.
Blood Analysis
Frozen samples were thawed only once before analysis. Serum insulin was
analyzed in duplicate by ELISA (ALPCO, Salem NH). Intra- and inter-assay
coefficient of variation (CV) were 5.3 and 7.2% respectively. Glucose and insulin
values were used to calculate an index of insulin resistance [HOMA-IR; calculated
as Glucose (mmol/L)?Insulin (mIU/mL)/22.5] [26]. Total ketones were deter-
mined by a cyclic enzymatic method that measures both acetoacetate (AcAc) and
3-hydroxybutyrate (3-HB) (Wako Chemicals USA Inc, Richmond, VA) with a
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sensitivity of 1.2 mmol/L, and intra- and inter-assay CV 7.7 and 20.3%
respectively. Plasma TG, CE, and PL were extracted and analyzed for fatty acid
methyl ester composition using capillary gas chromatography as previously
described [24]. Fatty acids were identified by comparison to authentic fatty acid
standards and quantitated with peak area and internal standard and expressed as
percent weight (wt%).
Statistical Analyses
One subject dropped after completing C4 due to a rise in his blood pressure. The
C5 and C6 data were interpolated based on mean percent changes for the group. A
paired samples t-test was used to examine the effects of 6-wk of very low
carbohydrate intake (Baseline vs C1). A repeated measures analysis of variance
(ANOVA) was used to assess changes across the six diet phases
(C1RC2RC3RC4RC5RC6) and Fisher’s LSD post hoc was used to examine
pairwise comparisons when significant main effects were observed. The alpha level
for significance was set at p #0.05.
Results
Dietary Intake
Total daily energy intake at baseline showed an average consumption of
3028 kcal/day with habitual carbohydrate intake at 44% of total energy, slightly
lower than the average American diet, while saturated fat intake was 14% of total
energy, slightly higher than the average American diet (Table 2). Energy intakes
during the controlled feeding periods averaged slightly over 2,500 kcal/day, which
was consistent with the goal to create a moderate caloric deficit. As designed,
energy and protein intakes across the 6 diet phases were constant for each person.
Compared to baseline (46 g/day), saturated fat intake was nearly doubled at C1
(84 g/day) and then gradually decreased to levels below baseline at C6 (32 g/day).
From C1 to C6, carbohydrate increased from 47 to 346 g/day corresponding to 7
and 55% of total energy, respectively. All diets were well tolerated and compliance
was high based on verbal communication and inspection of returned, unwashed
food containers.
Weight and Metabolic Responses
Relative to baseline, cumulative mean weight loss after the free-living, C1, C2, C3,
C4, C5 and C6 phases was -3.7, 26.6, 28.3, 28.8, 29.4, 29.9, and 29.8 kg,
respectively, the majority of which was comprised of fat (Fig 2A). Serum TG
concentrations were lower from C1 to C5 and increased to levels similar to
baseline at C6 (Fig 2B). Total serum cholesterol, LDL-C and HDL-C were not
significantly different across all diets. Compared to baseline, serum glucose
(P50.048), insulin (P50.004), HOMA (P50.006) (Fig 2C), systolic (P50.000)
and diastolic (P50.001) blood pressure (Fig 2D) were significantly lower at C1,
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but were not significantly different across the 6 diet phases. Compared to baseline,
serum ketones increased approximately 5-fold during C1, 3-fold after C2, 2-fold
after C4 and returned to baseline levels by C5. Respiratory exchange ratio
significantly decreased from baseline to C1 (0.80¡0.05 to 0.75¡0.04), and then
increased linearly at C2, C3, C4, C5, and C6 (0.77¡0.03, 0.79¡0.04, 0.80¡0.04,
0.82¡0.03, 0.84¡0.05, respectively) with values at C3, C4, C5, and C6 being
significantly higher than C1.
Saturated Fatty Acids
Despite a marked increase in dietary saturated fat intake from baseline to C1 (46
to 84 g/day) and then a progressive decrease to 32 g/day at C6, the proportion of
total SFA in plasma TG, CE, and PL were not significantly affected (Table 3).
From C1 to C6 when dietary saturated fat decreased from 84 to 32 g/day, it is
noteworthy that plasma total SFA actually increased in 56%, 88%, and 56% of
participants in the TG, CE, and PL fractions. Plasma 16:0, the predominant
saturated fatty acid, was not significantly different over time in the TG and CE
fractions. Compared to C1, plasma 16:0 in the PL lipid fraction was significantly
decreased at C2, C3, C4, and C5 but not at C6. Plasma 14:0 is a minor constituent
of total fatty acids but in all three plasma lipid fractions it showed more consistent
and significant decreases with carbohydrate restriction, and subsequent increases
with progressively higher levels of carbohydrate. As carbohydrate increased,
plasma 18:0 decreased in the TG fraction, but increased in the PL fraction,
although the absolute changes were relatively modest.
Table 2. Daily nutrient intakes at baseline (habitual diet) and during each dietary phase1.
Controlled Feeding Phases
Baseline2 C1 C2 C3 C4 C5 C6
Energy (kcal) 3028¡1049 2553¡327 2528¡339 2585¡286 2506¡333 2517¡339 2509¡336
Protein (g) 132¡44 129¡7 125¡6 125¡8 123¡10 123¡10 123¡11
Carbohydrate (g) 333¡149 47¡2 83¡4 131¡3 179¡2 251¡12 346¡28
Fat (g) 130¡44 209¡34 193¡35 179¡29 152¡34 121¡32 80¡27
SFA (g) 46¡19 84¡14 76¡15 71¡11 61¡15 49¡14 32¡11
MUFA (g) 33¡13 77¡14 64¡11 57¡8 48¡11 36¡10 24¡8
PUFA (g) 20¡10 31¡5 35¡8 35¡9 27¡7 24¡6 14¡5
Cholesterol (mg) 533¡218 844¡96 878¡91 824¡68 583¡131 448¡136 334¡154
Fiber (g) 27¡15 15¡1 19¡1 23¡4 27¡3 29¡2 35¡5
1Values are mean ¡ SD.
2Determined from 3-day diet records.
doi:10.1371/journal.pone.0113605.t002
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Monounsaturated Fatty Acids
Compared to baseline, palmitoleic acid was significantly (P50.000) decreased at
C1 in plasma TG (233%) and CE (249%) fractions and the response was highly
uniform, with all subjects showing a decrease from baseline to C1. Plasma TG and
CE palmitoleic acid showed a step-wise increase as carbohydrate was progressively
increased from C1 to C6 (Fig 3A). The subjects demonstrated a wide range of
palmitoleic acid levels at any given carbohydrate intake; however there was reduced
variance with lower carbohydrate diets (Fig 3B). There was also a noticeable
uniformity among subjects in their progressively higher palmitoleic acid levels going
from low- to moderate- to high-carbohydrate intakes. Similar to 18:0, as
carbohydrate increased plasma oleic acid (18:1n-9) decreased in the TG fraction,
but increased in the PL fraction, although the absolute changes were small.
Figure 2. Cumulative change from baseline in (A) body mass and fat mass from dual-energy x-ray absorptiometry, (B) fasting lipoproteins, (C)
insulin resistance determined from homeostatic model assessment (HOMA), and (D) blood pressure in 16 subjects who switched to a very low
carbohydrate diet and then incrementally increased carbohydrate every 3 wk over six sequential phases (C1RC2RC3RC4RC5RC6). BL 5
baseline, FL 5 free-living low-carbohydrate diet). Significant differences from Baseline vs C1 were determined by dependent t-test and indicated by an
asterisk. Differences from C1 to C6 were determined by repeated measures ANOVA and Fisher’s LSD post hoc. Different letters at a time point indicate
statistical significance.
doi:10.1371/journal.pone.0113605.g002
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Discussion
A cornerstone of dietary guidelines has been the restriction of saturated fat, but
that position is now being questioned in large part because recent analyses have
found that saturated fat intake is unrelated to risk of disease [2]. However, a
higher proportion of plasma saturated fat is related to increased risk of diabetes
and heart disease. Thus, there is a need to better understand the relationship
between dietary and plasma saturated fat. In this study, we sought to shed light on
the impact of replacing saturated fat with carbohydrate on plasma fatty acid
composition. Subjects were studied over 21 wk while consuming diets that were
progressively higher in carbohydrate and lower in fat. This ‘dose response’
protocol involved six levels of carbohydrate, which allowed us to examine how a
wide range of carbohydrate increments affected plasma fatty acid composition
Table 3. Plasma fatty acid responses1.
Controlled Feeding Phases2 P-Value
Free-Living3 C1 C2 C3 C4 C5 C6 T-Test4 ANOVA5
Triglyceride (wt%)
14:0 1.02¡0.30 0.99¡0.38a 1.09¡0.33a 1.28¡0.44ac 1.27¡0.75ac 1.62¡0.89bc 1.79¡0.98b 0.002 0.000
16:0 23.94¡1.95 24.36¡1.63 23.96¡1.15 24.34¡2.01 24.92¡3.51 25.50¡3.63 25.65¡4.15 0.268 0.150
18:0 4.06¡0.92 4.00¡0.78a 3.84¡0.75ac 3.82¡0.75 ac 3.73¡0.83a 3.61¡0.75bc 3.45¡0.63b 0.078 0.027
16:1 2.92¡0.61 2.59¡0.58a 2.79¡0.77ac 3.15¡0.92bc 3.09¡1.03bc 3.61¡1.22d 3.89¡1.26d 0.000 0.000
18:1 37.04¡3.70 36.83¡2.76a 37.13¡1.89a 35.87¡2.47ab 36.25¡2.97ab 35.81¡3.31ab 35.09¡3.09b 0.126 0.050
SFA 29.72¡2.54 29.82¡1.83 29.45¡1.24 29.95¡2.24 30.43¡4.50 31.19¡4.69 31.38¡5.31 0.242 0.294
MUFA 40.80¡3.90 40.27¡3.14 40.81¡2.50 39.80¡2.43 40.09¡2.70 40.17¡3.31 39.79¡2.95 0.438 0.731
Cholesteryl Ester (wt%)
14:0 0.69¡0.78 0.65¡0.42a 0.67¡0.44ab 0.90¡0.57bc 0.79¡0.41abc 0.80¡0.31abc 1.01¡0.47c 0.005 0.032
16:0 11.31¡1.62 11.17¡1.25 11.07¡1.25 10.88¡1.32 10.66¡0.74 10.66¡1.36 11.34¡1.00 0.579 0.188
18:0 0.99¡0.40 0.92¡0.38 1.01¡0.53 1.20¡0.84 0.94¡0.42 0.96¡0.51 1.06¡0.58 0.168 0.143
16:1 1.90¡0.50 1.72¡0.38a 2.23¡1.35b 2.69¡1.45bc 2.31¡1.00b 2.40¡1.17bc 2.84¡1.28c 0.000 0.001
18:1 15.92¡1.40 15.98¡1.37 15.89¡1.37 15.53¡2.09 15.49¡1.53 15.20¡1.85 16.17¡1.26 0.963 0.338
SFA 13.39¡2.30 13.21¡2.12 13.24¡2.14 13.62¡3.33 12.89¡1.68 12.90¡2.18 14.34¡2.39 0.231 0.113
MUFA 18.23¡1.56 17.95¡1.42 18.50¡2.33 18.73¡3.51 18.18¡1.97 18.03¡2.56 19.44¡1.99 0.034 0.258
Phospholipid (wt%)
14:0 0.27¡0.13 0.30¡0.14a 0.28¡0.09a 0.33¡0.10ab 0.34¡0.12bc 0.38¡0.14cd 0.37¡0.11bd 0.044 0.000
16:0 26.90¡1.63 27.52¡1.49a 26.82¡1.72b 26.29¡1.67b 26.72¡1.87bc 26.24¡1.75b 26.97¡2.09ac 0.001 0.001
18:0 13.68¡1.47 13.13¡1.20a 13.44¡1.55ab 13.79¡1.71b 13.71¡1.44b 13.68¡1.59b 13.88¡1.77b 0.000 0.048
16:1 0.57¡0.17 0.61¡0.31a 0.55¡0.16a 0.60¡0.22a 0.60¡0.23a 0.63¡0.20ab 0.74¡0.26b 0.055 0.030
18:1 8.09¡0.81 8.23¡0.59a 8.05¡0.47ac 8.22¡0.82a 8.37¡0.62a 8.53¡0.81abc 8.75¡0.80b 0.074 0.005
SFA 43.17¡2.49 43.22¡1.41 42.98¡2.17 42.80¡1.65 43.10¡1.70 43.56¡1.65 43.56¡1.74 0.489 0.114
MUFA 11.07¡1.19 11.21¡1.27 11.20¡1.52 10.99¡1.21 11.05¡0.93 11.22¡0.90 11.51¡1.24 0.421 0.396
1Values are mean ¡ SD from 16. SFA 5 total saturated fatty acids; MUFA 5 total monounsaturated fatty acids.
2C1 5 lowest carbohydrate diet and C6 5 highest carbohydrate intake.
33wk run-in diet phase before entering feeding portion of study.
4Dependent t-test (Baseline vs C1).
doi:10.1371/journal.pone.0113605.t003
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within the same person. The results showed that increasing intake of dietary
saturated fat did not accumulate in plasma lipid fractions when carbohydrate was
restricted, and moreover when dietary saturated fat intake was decreased there was
not a consistent decrease in plasma saturated fat. Whereas plasma saturated fat
did not associate with dietary carbohydrate or saturated fat; plasma palmitoleic
acid, a biomarker associated with increased risk of hyperglycemia, insulin
resistance, metabolic syndrome, and type-2 diabetes, tracked incrementally with
dietary carbohydrate.
Several lines of evidence point to endogenously produced palmitoleic acid (i.e.,
cis-16:1n-7) as being associated with dietary carbohydrate intake. In a large
population consuming high-carbohydrate diets, there were incremental increases
in erythrocyte palmitoleic acid across quartiles of carbohydrate intake ranging
Figure 3. (A) Change from baseline in plasma palmitoleic acid (16:1) in triglyceride (TG) and cholesteryl ester (CE) in subjects who consumed a very low
carbohydrate diet (C1) and then gradually transitioned to a high carbohydrate diet over six sequential phases (C1RC2RC3RC4RC5RC6). (B) Individual
responses in plasma TG 16:1 from C1 to C4 to C6 corresponding to 47, 179, and 344 g carbohydrate/day. Open circles are subjects who went from low- to
high-carbohydrate, and shaded triangles are subjects who went from high- to low-carbohydrate intake.
doi:10.1371/journal.pone.0113605.g003
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from 273 to 419 g/day [9]. In our previous hypocaloric and isocaloric very low-
carbohydrate diet studies, we observed consistent decreases in plasma palmitoleic
acid independent of fat composition and weight loss. The current results provide
additional data that dietary carbohydrate is a primary driver of plasma palmitoleic
acid. Subjects who progressively increased carbohydrate from 47 to 346 g/day
showed a step-wise increase in plasma palmitoleic acid.
There was remarkable uniformity in the pattern of plasma palmitoleic acid
responses as a function of dietary carbohydrate, although the individual
trajectories varied. There was also significant variability between individuals
during each diet phase with greater variance as carbohydrate increased (Fig 3B).
For example, at a carbohydrate intake of 47 g/day TG palmitoleic acid varied from
,2 to 4 wt%, whereas at 346 g/day it varied from 2 to 7 wt%. Higher proportions
of palmitoleic acid in blood or adipose tissue are consistently associated with a
myriad of undesirable outcomes such as obesity [27, 28], hypertriglyceridemia
[29], hyperglycemia [15], inflammation [30, 31], metabolic syndrome [8, 9, 30],
type-2 diabetes [10–14], coronary disease [32], heart failure [33], and incidence
and aggressiveness of prostate cancer [21]. It is difficult to assign a specific
threshold above which palmitoleic acid confers an increased risk of developing
these conditions. In the Physician’s Health Study a one standard deviation
increase in plasma palmitoleic acid was associated with a 17% higher odds ratio of
congestive heart failure [33]. In obese subjects who lost significant weight, higher
adipose tissue palmitoleic acid before the diet was associated with failure to
maintain weight loss [27]. Since the presence of palmitoleic acid is an indicator of
de novo fatty acid synthesis [3], as there is little palmitoleate in common dietary
fats, its rising proportion may serve as a proxy of carbohydrate flux through non-
oxidative disposal pathways and a harbinger of adverse clinical outcomes.
In regards to total plasma SFA, the pattern of response was more variable than
palmitoleic acid. Similar to our previous studies [24, 25], when dietary saturated
fat was increased in the context of a very low-carbohydrate intake, the proportion
of total plasma SFA was not increased. In this study saturated fat intake at baseline
was increased by 38 g/day at C1 through regular consumption of whole eggs, full
fat dairy, and high-fat meats. The lack of accumulation of this additional saturated
fat was likely due in part to greater oxidation of SFA, as indicated by the
significant decrease in respiratory exchange ratio during C1. Whole body fat
oxidation increases markedly when dietary carbohydrate is restricted [34], and it
is likely that SFA become preferred substrates for beta-oxidation in low-
carbohydrate-adapted individuals.
Carbohydrate-induced insulin secretion stimulates DNL and potently sup-
presses lipolysis and fat oxidation [35], which would promote accumulation of
endogenous SFA even when they are reduced in the diet. In the current study,
dietary saturated fat was decreased by more than half from C1 to C6 (84 to 32 g/
day), yet the majority of participants showed a numerical increase in plasma SFA
in all lipid fractions over this same time period. The relative contribution of DNL
and fat oxidation and their sensitivity to dietary carbohydrate manipulation likely
varies considerably between people and explains the less uniform response in total
Carbohydrate Effects on Saturated Fatty Acids and Palmitoleic Acid
PLOS ONE | DOI:10.1371/journal.pone.0113605 November 21, 2014 12 / 16
plasma SFA observed in the current study. However, the pattern of lower plasma
SFA after the low-carbohydrate diet with the highest amount of saturated fat, and
numerically higher plasma SFA after the high-carbohydrate diet with the least
amount of saturated fat, is consistent with the regulation of DNL and fat
oxidation by carbohydrate intake and its effect on the glucose-insulin axis.
The reduced proportion of plasma palmitoleic acid after the low-carbohydrate
diet was associated with positive responses in other traditional risk markers.
Serum triglycerides, glucose, insulin, and estimates of insulin sensitivity were
improved as well. Serum cholesterol responses were variable but consistent with
the known effects of carbohydrate restriction to increase, on average, total
cholesterol, HDL-C and LDL-C relative to low-fat diets [36].
There were several limitations in this study. The diet phases were relatively
short to keep the entire feeding portion of study less than 6 months, and by design
we created menus that were hypocaloric to induce weight loss. The highest
carbohydrate intake was only 55% of total energy and it was consumed in the
context of a daily caloric deficit and ongoing weight loss for most subject.
Whether carbohydrate-induced increases in plasma palmitoleic acid would have
been similar or more pronounced in the context of eucaloric weight maintenance
diets remains unknown. Furthermore, since subjects initially restricted carbohy-
drates and then sequentially added them back over time it is difficult to
disassociate temporal changes that may be influenced by cumulative weight loss or
lingering effects from the previous diet phases. To address this limitation we
provided the diets in reverse order (i.e., high- to low-carbohydrate) to a small
number of participants (n55). In these individuals, plasma palmitoleic acid
responded in the exact opposite pattern as the primary group providing strong
evidence that the major driver of circulating palmitoleic acid was the level of
carbohydrate in the diet, and was not significantly modified by the order of diets,
length of each diet phase, or weight loss (data not shown).
In summary, high intakes of saturated fat (including regular consumption of
whole eggs, full-fat dairy, high-fat beef and other meats) does not contribute to
accumulation of plasma SFA in the context of a low carbohydrate intake. A
progressive decrease in saturated fat and commensurate increase in carbohydrate
intake, on the other hand, is associated with incremental increases in the
proportion of plasma palmitoleic acid, which may be signaling impaired
metabolism of carbohydrate, even under conditions of negative energy balance
and significant weight loss. These findings contradict the perspective that dietary
saturated fat per se is harmful, and underscore the importance of considering the
level of dietary carbohydrate that accompanies saturated fat consumption.
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